Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

During the Trading Day
131.25 -0.63 / -0.48%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
131.25 0.00 / 0.00%
 
Volume: 311.2K

Today’s Trading

Previous close131.88
Today’s open132.83
Day’s range130.77 - 133.00
Volume3,546,098
Average volume (3 months)4,645,687
Market cap$104.3B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.27%
Earnings growth (next 5 years)+24.56%
Revenue growth (last year)+17.89%
P/E ratio44.8
Price/Sales12.24
Price/Book16.17

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.15-0.34%
BMYBristol-Myers Squibb+1.18+1.83%
ABBVAbbVie-0.15-0.21%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts